Home/Filings/4/0000899243-23-011231
4//SEC Filing

PERRY DAVID P 4

Accession 0000899243-23-011231

CIK 0001832415other

Filed

Apr 11, 8:00 PM ET

Accepted

Apr 12, 9:44 PM ET

Size

12.5 KB

Accession

0000899243-23-011231

Insider Transaction Report

Form 4
Period: 2023-04-10
PERRY DAVID P
DirectorSee Remarks10% Owner
Transactions
  • Purchase

    Common Stock

    2023-04-10$0.82/sh+3,636,364$3,000,0003,636,364 total(indirect: By Trust)
  • Purchase

    Common Stock

    2023-04-10$0.82/sh+1,333,333$1,100,00011,797,348 total(indirect: By Trust)
Holdings
  • Common Stock

    (indirect: By Trust)
    21,336
  • Common Stock

    101,536
  • Common Stock

    (indirect: By Spouse)
    293,150
Transactions
  • Purchase

    Common Stock

    2023-04-10$0.82/sh+1,333,333$1,100,00011,797,348 total(indirect: By Trust)
  • Purchase

    Common Stock

    2023-04-10$0.82/sh+3,636,364$3,000,0003,636,364 total(indirect: By Trust)
Holdings
  • Common Stock

    (indirect: By Spouse)
    293,150
  • Common Stock

    101,536
  • Common Stock

    (indirect: By Trust)
    21,336
Footnotes (7)
  • [F1]On April 6, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.825 per share.
  • [F2]As one of the PIPE Investors, the David P. Perry 2015 Trust (the "Perry Trust") acquired 1,333,333 shares of Issuer common stock on April 10, 2023 for $0.825 per share.
  • [F3]These shares are owned directly by the Perry Trust, a ten percent owner of the Issuer, and indirectly by David P. Perry ("Perry") as trustee of the Perry Trust. Perry is an officer, director and ten percent owner of the Issuer.
  • [F4]As one of the PIPE Investors, the Georgianna Maule-Ffinch 2015 Trust (the "Maule-Ffinch Trust") acquired 3,636,364 shares of Issuer common stock on April 10, 2023 for $0.825 per share.
  • [F5]These shares are owned directly by the Maule-Ffinch Trust, a ten percent owner of the Issuer, and indirectly by Perry's spouse, Georgianna Maule-Ffinch ("Maule-Ffinch"), as the sole trustee of the Maule-Ffinch Trust, for the benefit of Maule-Ffinch and her children. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F6]These shares are owned directly by Maule-Ffinch.
  • [F7]These shares are owned directly by Donald R. Leo, Trustee of Pensus Limited Trust dated 06/12/2010 FBO Georgianna Maule-Ffinch (the "Pensus Limited Trust") for the benefit of Maule-Ffinch. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Issuer

Better Therapeutics, Inc.

CIK 0001832415

Entity typeother

Related Parties

1
  • filerCIK 0001105941

Filing Metadata

Form type
4
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 9:44 PM ET
Size
12.5 KB